501. Friend of GATA2 Variant Ser657Gly Is Associated With Coronary Microvascular Disease.
作者: Marie A Guerraty.;Shefali S Verma.;Yi-An Ko.;Michael A McQuillan.;Donna M Conlon.;John W Tobias.;Michael G Levin.;William Haury.;Fangyuan Zheng.;Tess Cherlin.;Chao Zhang.;Renae Judy.;Sarah A Tishkoff.;Scott M Damrauer.;Zoltan Arany.;Daniel J Rader.
来源: Circ Genom Precis Med. 2026年19卷2期e005342页
The coronary microvasculature is crucial for proper cardiac function, and coronary microvascular disease (CMVD) has emerged as an underdiagnosed and undertreated cause of ischemic heart disease. FOG2 (friend of GATA 2) is a transcriptional co-regulator crucial for coronary development and the maintenance of the coronary microvasculature in adult mice. Little is known about the role of FOG2 in humans or its role in CMVD. Here, we report a genotype-first approach to determine the role of FOG2 in human CMVD.
502. Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study.
作者: Mats C Højbjerg Lassen.;John W Ostrominski.;Brian L Claggett.;Chiadi E Ndumele.;Tor Biering-Sørensen.;Kunihiro Matsushita.;Elizabeth Selvin.;Josef Coresh.;Amil Shah.;Scott D Solomon.;Muthiah Vaduganathan.
来源: Circulation. 2026年153卷17期1268-1280页
Suboptimal cardiovascular-kidney-metabolic (CKM) health is highly prevalent in the United States, especially among older adults, but whether the CKM syndrome staging framework is predictive of incident heart failure (HF) in this population remains uncertain.
503. Safety and Chronic Atrial Lesion Formation With a Large-Tip, Contact-Force-Sensing Multipolar Pulsed Field Ablation Catheter: Effect of Application Number in a Porcine Beating Heart Model.
作者: Luigi Di Biase.;Jacopo Marazzato.;Marco Schiavone.;Fengwei Zou.;Taylor Spangler.;Rahul Bhardwaj.;Jonathan Hsu.;Assaf Govari.;Andreas Altman.;Kevin Okarski.;Tushar Sharma.;Paras Parikh.;Christopher Beeckler.;Terrence Troutman.;Qi Chen.;Hiroshi Nakagawa.;William Maddox.;Devi Nair.;Sanghamitra Mohanty.;Vincenzo Mirco La Fazia.;Domingo Ynoa.;Aung Lin.;Andrea Natale.;Xiaodong Zhang.
来源: Circ Arrhythm Electrophysiol. 2026年19卷4期e014473页
Integration of catheter-tissue contact force with pulsed field ablation (PFA) dosing is essential for achieving safe and durable lesion formation with contact force sensing catheters in ventricular models. However, data on the use of these catheters for atrial ablation remain limited. This study evaluated the procedural safety and 30-day lesion characteristics of atrial PFA delivered with the OMNYPULSE ablation catheter in a porcine model.
504. Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement.
作者: Teresa Maria Capovilla.;Manuela Iseppi.;Salvatore Distaso.;Marta Gigli.;Matteo Dal Ferro.;Michele Moretti.;Annamaria Iorio.;Antonella Mancinelli.;Marco Merlo.;Luisa Mestroni.;Alessia Paldino.;Gianfranco Sinagra.
来源: Circ Genom Precis Med. 2026年19卷2期e005528页 505. Differential Impact of Low Voltage Area Radiofrequency Ablation on Recurrence of Atrial Fibrillation Versus Atrial Tachycardia in Patients With Persistent Atrial Fibrillation.
作者: Daisuke Sakamoto.;Akihiro Sunaga.;Yuki Matsuoka.;Hideaki Hasegawa.;Hirota Kida.;Tomoharu Dohi.;Daisaku Nakatani.;Katsuki Okada.;Tetsuhisa Kitamura.;Masaharu Masuda.;Nobuaki Tanaka.;Tetsuya Watanabe.;Hitoshi Minamiguchi.;Yasuyuki Egami.;Takafumi Oka.;Tomoko Minamisaka.;Takashi Kanda.;Masato Okada.;Masato Kawasaki.;Yasuhiro Matsuda.;Koji Tanaka.;Nobuhiko Makino.;Shungo Hikoso.;Koichi Inoue.;Yohei Sotomi.;Yasushi Sakata.; .
来源: Circ Arrhythm Electrophysiol. 2026年19卷4期e014408页 506. 2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.
作者: Alice H Lichtenstein.;Amit Khera.;Cheryl A M Anderson.;Lawrence J Appel.;Dana M DeSilva.;Christopher Gardner.;Frank B Hu.;Daniel W Jones.;Kristina S Petersen.; .
来源: Circulation. 2026年
Poor diet quality is strongly associated with elevated cardiovascular disease morbidity and mortality risk. This American Heart Association scientific statement for food-based cardiovascular health optimization and cardiovascular disease risk reduction guidance summarizes available evidence and provides contextual guidance for the key features of heart-healthy dietary patterns. It enumerates collateral benefits of adopting a heart-healthy dietary pattern in terms of nutrient intake adequacy and compatibility with other chronic disease risk reduction guidance. The features of a heart-healthy dietary pattern include (1) adjusting energy intake and expenditure to achieve and maintain a healthy body weight; (2) eating plenty of vegetables and fruits and choosing a wide variety; (3) choosing foods made mostly with whole grains rather than refined grains; (4) choosing healthy sources of protein; (5) choosing sources of unsaturated fats in place of sources of saturated fat; (6) choosing minimally processed foods instead of ultraprocessed foods; (7) minimizing intake of added sugars in beverages and foods; (8) reducing sodium intake by choosing foods low in sodium and preparing foods with minimal or no salt; and (9) if alcohol is not consumed, do not start; if alcohol is consumed, limit intake.
507. MR-ProADM Predicts Mortality and Heart Failure Events in ATTR Cardiac Amyloidosis.
作者: Belén Peiró-Aventín.;Elena Revuelta-Lopez.;Mariana Brandao.;Julio Nuñez.;Manuel A Fernández-Rojo.;Rosa M Carmona.;Borja Montejo.;Alejandro Ferrando-Muñoz.;Aránzazu Martín-García.;Esther Gonzalez-Lopez.;Fernando Dominguez.;Andrea Camblor.;María Ruiz-Cueto.;Josep Lupon.;Sergio Teryua.;Dimitrios Bampatsias.;Israt Jahan.;Ana Royuela.;Ahmad Masri.;Mathew S Maurer.;Antoni Bayes-Genis.;Pablo Garcia-Pavia.
来源: Circulation. 2026年153卷18期1350-61页
With the increasing diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) at earlier stages and new therapies, there is a rising demand for tools to stratify risk and prognosis. We evaluated the prognostic value of multiple circulating biomarkers for predicting outcomes in ATTR-CM.
508. Optimal Ablation Strategies for Persistent Atrial Fibrillation With Heart Failure: Three-Year Follow-Up of a Prospective Multicenter Randomized Trial.
作者: Kaige Li.;Xinhua Wang.;Mu Qin.;Ping Ye.;Bing Han.;Weifeng Jiang.;Yu Zhang.;Qidong Zheng.;Anjing Ji.;Menghe Zhang.;Yanzhe Wang.;Shaohui Wu.;Kai Xu.;Changhao Xu.;Xu Liu.;Xumin Hou.
来源: Circ Arrhythm Electrophysiol. 2026年19卷4期e014394页
Catheter ablation has been shown to improve prognosis in patients with heart failure (HF) and atrial fibrillation (AF); however, the optimal ablation strategy remains undefined.
509. Effects of Left Atrial Filling Pressure on Exercise Pulmonary Gas Exchange in HFpEF: Does the V-Wave Matter?
作者: Le Huang.;Bryce N Balmain.;James P MacNamara.;Tiffany L Brazile.;Michael G Leahy.;Christopher M Hearon.;Denis J Wakeham.;Andrew R Tomlinson.;Tony G Babb.;Benjamin D Levine.;Satyam Sarma.
来源: Circ Heart Fail. 2026年19卷5期e013383页 511. Clinical Impact of Rare Variants in Racial and Ethnic Minorities With Atrial Fibrillation.
作者: Michael C Hill.;Brandon Chalazan.;Shashank Sandu.;Joshua H Arnold.;Peter Boxley.;Anish S Shah.;Siddharth Bhayani.;Hajwa Kim.;Victor Qiao.;Ashwini Deshpande.;Mahmud Arif Pavel.;David S Tofovic.;Dawood Darbar.
来源: Circ Arrhythm Electrophysiol. 2026年19卷4期e014641页 512. Win Ratio Analysis of an Extensive Ablation Strategy in Patients With Persistent Atrial Fibrillation: Insights From the EARNEST-PVI Randomized Trial.
作者: Yuki Matsuoka.;Akihiro Sunaga.;Daisuke Sakamoto.;Hideaki Hasegawa.;Daisaku Nakatani.;Katsuki Okada.;Hirota Kida.;Tetsuhisa Kitamura.;Nobuaki Tanaka.;Masaharu Masuda.;Tetsuya Watanabe.;Hitoshi Minamiguchi.;Yasuyuki Egami.;Takafumi Oka.;Miwa Miyoshi.;Masato Okada.;Yasuhiro Matsuda.;Masato Kawasaki.;Koichi Inoue.;Shungo Hikoso.;Tomoharu Dohi.;Yohei Sotomi.;Yasushi Sakata.; .
来源: Circ Arrhythm Electrophysiol. 2026年19卷4期e014463页 513. Single-Nuclei Transcriptomic Profiling of Human Myocardium in Long-Chain 3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency.
作者: Hanna J Tadros.;Diwakar Turaga.;Yi Zhao.;Chang-Ru Tsai.;Lalita Wadhwa.;Debra L Kearney.;Iki Adachi.;Xiao Li.;James F Martin.
来源: Circ Heart Fail. 2026年19卷5期e014092页 514. Correction to: Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
作者: Mariann R Piano.;Gregory M Marcus.;Dawn M Aycock.;Jennifer Buckman.;Chueh-Lung Hwang.;Susanna C Larsson.;Kenneth J Mukamal.;Michael Roerecke.; .
来源: Circulation. 2026年153卷13期e1106页 518. Transient Sprr1a Expression Defines a Population of Border Zone Cardiomyocytes That Survive Ischemic Injury.
作者: Emily H Marshall.;Daniel A Zuppo.;Kimberly N Burgos Villar.;Adwiteeya Misra.;Deanne M Mickelsen.;Ronald A Dirkx.;Eric M Small.
来源: Circulation. 2026年153卷13期1001-1004页 519. Response by Gao et al to Letter Regarding Article, "G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice". |